Aibili Logo Association for Innovation and Biomedical Research on Light

What's new


19th May 2017
Clinical Trials Day
The European Clinical Research Infrastructure Network (ECRIN) announced that its 2017 celebration of International Clinical Trials Day (ICTD) will take place in Lisbon, Portugal on 19 May 2017. The theme of this year’s event is ‘Data sharing and reuse: attitudes and practices in multinational clinical research’. AIBILI will present two communications on Certified Data Centre and Pharmacovigilance in Clinical Trials. For more information please consult PtCRIN.

11th May 2017
AIBILI @ ARVO 2017
Please see here the participation of AIBILI at the ARVO Meeting 2017.

9th May 2017
Pharmacovigilance: Updates on drug safety – quarterly publication; Vol. 4, Nº 1 // Farmacovigilância: Atualizações de segurança de medicamentos – Vol. 4, Nº 1
Pharmacovigilance: Updates on drug safety is a quarterly publication issued by the Portuguese Central Regional Pharmacovigilance Unit (UFC) delivering to patients and healthcare professionals information on the risks and safe use of medicines.

Farmacovigilância: Atualizações de segurança de medicamentos é uma publicação trimestral editada pela Unidade de Farmacovigilância do Centro (UFC) com o objetivo de disponibilizar informação de segurança dos medicamentos aos utentes e profissionais de saúde

6th March 2017
Workshop on OCT-Angiography
AIBILI has organized a workshop dedicated to OCT-Angiography on 07/04/2017. Please download here the programme.

2nd March 2017
Prof. José Cunha-Vaz talks about the crucial role played by the blood-retinal barrier
Prof. José Cunha-Vaz talks to EUROTIMES about the crucial role played by the blood-retinal barrier (BRB) in the regulation of the micro-environment of the retina, with breakdown of the BRB directly implicated in the development of a range of retinal diseases such as diabetic retinopathy (DR) and age-related macular degeneration (AMD). Please see here the interview.

23rd February 2017
Workshop on Clinical Research
AIBILI organized a workshop dedicated to Clinical Research - Supporting Structures and Networks on 23/02/2017. Please download here the programme.

31st January 2017
Pharmacovigilance: Updates on drug safety – quarterly publication; Vol. 3, Nº 4 // Farmacovigilância: Atualizações de segurança de medicamentos – Vol. 3, Nº 4
Pharmacovigilance: Updates on drug safety is a quarterly publication issued by the Portuguese Central Regional Pharmacovigilance Unit (UFC) delivering to patients and healthcare professionals information on the risks and safe use of medicines.

Farmacovigilância: Atualizações de segurança de medicamentos é uma publicação trimestral editada pela Unidade de Farmacovigilância do Centro (UFC) com o objetivo de disponibilizar informação de segurança dos medicamentos aos utentes e profissionais de saúde.

23rd November 2016
AIBILI will coordinate an European Clinical Trial funded by IMI2
A Consortium led by the University of Bonn, in Germany, of which AIBILI is a Partner was awarded with an IMI2 grant of 16M€. [read more]

8th November 2016
A IMPORTÂNCIA DA NOTIFICAÇÃO DE REAÇÕES ADVERSAS A MEDICAMENTOS (RAM)
[read more]

4th November 2016
Workshop on Pharmacovigilance
AIBILI wiil organize a Pharmacovigilance Workshop. Please download here the programme.

2nd November 2016
Pharmacovigilance: Updates on drug safety – quarterly publication; Vol. 3, Nº 3 // Farmacovigilância: Atualizações de segurança de medicamentos – Vol. 3, Nº 3
Pharmacovigilance: Updates on drug safety is a quarterly publication issued by the Portuguese Central Regional Pharmacovigilance Unit (UFC) delivering to patients and healthcare professionals information on the risks and safe use of medicines.

Farmacovigilância: Atualizações de segurança de medicamentos é uma publicação trimestral editada pela Unidade de Farmacovigilância do Centro (UFC) com o objetivo de disponibilizar informação de segurança dos medicamentos aos utentes e profissionais de saúde

18th October 2016
AAO - Poster Hotspot
Fruit-Rich Mediterranean Diet with Antioxidants May Cut Age-Related Macular Degeneration Risk by More than a Third.
Study is first to show that caffeine could be protective against AMD. Please find here the press release.

8th September 2016
Prof. Cunha-Vaz receives the EURETINA Award 2016
Prof. Cunha-Vaz received the EURETINA Award 2016 during the open cerimony of the EURETINA 2016 Congress that take place in Copenhagen, Denmark, on September 8, 2016. Please find here the Press Release.

28th July 2016
Pharmacovigilance: Updates on drug safety – quarterly publication; Vol. 3, Nº 2 // Farmacovigilância: Atualizações de segurança de medicamentos – Vol. 3, Nº 2
Pharmacovigilance: Updates on drug safety is a quarterly publication issued by the Portuguese Central Regional Pharmacovigilance Unit (UFC) delivering to patients and healthcare professionals information on the risks and safe use of medicines.

Farmacovigilância: Atualizações de segurança de medicamentos é uma publicação trimestral editada pela Unidade de Farmacovigilância do Centro (UFC) com o objetivo de disponibilizar informação de segurança dos medicamentos aos utentes e profissionais de saúde

15th July 2016
TecnoHospital intreview with Prof. Cunha-Vaz
Please find here the interview in the TecnoHospital edition of May/June 2016.

27th May 2016
Major UK study confirms effectiveness of ground-breaking RETMARKER Diabetic Retinopathy screening technology
British researchers involved in an observational study consisting of 20,258 patients from the NHS’ (National Health Service) Diabetic Eye Screening Programme have announced their first set of results at the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Seattle, USA. The study’s team of researchers qualified all of the available technologies that met their eligibility criteria before submitting them for independent evaluation. Retmarker was the only European technology to be approved by the study based on its adequate sensitivity for detecting referable retinopathy in a high-volume clinical setting when compared with existing quality-assured, real-world methods that rely on human graders. Additionally, Retmarker showed adequate specificity that qualifies it as a more cost-effective alternative. Please find here the Press Release.

22nd April 2016
Pharmacovigilance: Updates on drug safety – quarterly publication; Vol. 3, Nº 1; 22/04/2016 // Farmacovigilância: Atualizações de segurança de medicamentos – Vol. 3, Nº 1; 22/04/2016
Pharmacovigilance: Updates on drug safety is a quarterly publication issued by the Portuguese Central Regional Pharmacovigilance Unit (UFC) delivering to patients and healthcare professionals information on the risks and safe use of medicines. Farmacovigilância: Atualizações de segurança de medicamentos é uma publicação trimestral editada pela Unidade de Farmacovigilância do Centro (UFC) com o objetivo de disponibilizar informação de segurança dos medicamentos aos utentes e profissionais de saúde

5th April 2016
AIBILI Data Centre Certification
AIBILI Data Centre is now Certified by ECRIN requirements for IT and Data Management within Clinical Trials.

5th February 2016
Pharmacovigilance: Updates on drug safety – quarterly publication; Vol. 2, Nº 4; 05/02/2016 // Farmacovigilância: Atualizações de segurança de medicamentos – Vol. 2, Nº 4; 05/02/2016
Pharmacovigilance: Updates on drug safety is a quarterly publication issued by the Portuguese Central Regional Pharmacovigilance Unit (UFC) delivering to patients and healthcare professionals information on the risks and safe use of medicines. Farmacovigilância: Atualizações de segurança de medicamentos é uma publicação trimestral editada pela Unidade de Farmacovigilância do Centro (UFC) com o objetivo de disponibilizar informação de segurança dos medicamentos aos utentes e profissionais de saúde

15th December 2015
AIBILI received the Pfizer Award 2015 for Clinical Research
Prof. Cunha-Vaz and Torcato Santos received the Pfizer Award 2015 for Clinical Research with their work Automated analysis of retinal extracellular space using Spectral Domain Optical Coherence Tomography. A non-invasive indirect identification of the sites of alterations of the Blood-Retinal Barrier. Please find here the press realease.

4th December 2015
Workshop "Associações farmacêuticas fixas de substâncias ativas de diferentes grupos farmacoterapêuticos na prevenção da doença cardiovascular"
This workshop was held in Coimbra on 04/12/2015. See programme.

14th November 2015
World Diabetes Day
As every year, November 14th is World Diabetes Day (WDD), the first global awareness campaign on Diabetes. The main and most feared complication of diabetes, Diabetic Retinopathy, is a chronic eye condition that eventually develops in up to 90% of people living with type-1 diabetes (and 60% with type-2).  A group of leading European scientists, ophthalmologists and endocrinologists gathered three years ago to create EUROCONDOR: the European Consortium for the Early Treatment of Diabetic Retinopathy. Please find herethe press release.

13th October 2015
Pharmacovigilance: Updates on drug safety – quarterly publication; Vol. 2, Nº 3; 13/10/2015 // Farmacovigilância: Atualizações de segurança de medicamentos – Vol. 2, Nº 3; 13/10/2015
Pharmacovigilance: Updates on drug safety is a quarterly publication issued by the Portuguese Central Regional Pharmacovigilance Unit (UFC) delivering to patients and healthcare professionals information on the risks and safe use of medicines. Farmacovigilância: Atualizações de segurança de medicamentos é uma publicação trimestral editada pela Unidade de Farmacovigilância do Centro (UFC) com o objetivo de disponibilizar informação de segurança dos medicamentos aos utentes e profissionais de saúde

27th July 2015
Pharmacovigilance: Updates on drug safety – quarterly publication; Vol. 2, Nº 2; 27/07/2015 // Farmacovigilância: Atualizações de segurança de medicamentos – Vol. 2, Nº 2; 27/07/2015
Pharmacovigilance: Updates on drug safety is a quarterly publication issued by the Portuguese Central Regional Pharmacovigilance Unit (UFC) delivering to patients and healthcare professionals information on the risks and safe use of medicines. Farmacovigilância: Atualizações de segurança de medicamentos é uma publicação trimestral editada pela Unidade de Farmacovigilância do Centro (UFC) com o objetivo de disponibilizar informação de segurança dos medicamentos aos utentes e profissionais de saúde.

7th April 2015
Prof. Cunha-Vaz receives the Health National Award 2014
Prof. Cunha-Vaz has received today the Health National Award 2014 by the Portuguese Minister of Health in a ceremony that took place in Lisbon. Please download here the press release.

27th February 2015
Pharmacovigilance: Updates on drug safety – quarterly publication; Vol. 1, Nº 4; 27/01/2015 // Farmacovigilância: Atualizações de segurança de medicamentos – Vol. 1, Nº 4; 27/01/2015
Pharmacovigilance: Updates on drug safety is a quarterly publication issued by the Portuguese Central Regional Pharmacovigilance Unit (UFC) delivering to patients and healthcare professionals information on the risks and safe use of medicines. Farmacovigilância: Atualizações de segurança de medicamentos é uma publicação trimestral editada pela Unidade de Farmacovigilância do Centro (UFC) com o objetivo de disponibilizar informação de segurança dos medicamentos aos utentes e profissionais de saúde.

11th February 2015
Upon Retmarker application, EMA issues Letter of Support for Micro-Aneurysm Formation Rate biomarker
Micro-Aneurysm Formation Rate as calculated by a validated automated method seems a very promising biomarker for enriching a patient population at higher risk for the development of Clinically Significant Macular Oedema. The Retmarker Company (formerly known as Critical Health) is in a process to qualify the Micro-Aneurysm Formation Rate (MAFR), measured with a validated automated method as an enrichment biomarker for studies of clinically significant macular oedema (CSMO), a sight-threatening complication of Diabetic Retinopathy (DR). Such biomarker could be used to enrich a clinical trial population to those at higher risk of developing CSMO. Please download here the press release.

11th December 2014
AIBILI receives from APIFARMA the distinction of Excelence Partner in Research
During a commemoration ceremony of the 75th anniversary of APIFARMA AIBILI received from APIFARMA the distinction of Excelence Partner in Research.

19th November 2014
AIBILI 25th Anniversary
AIBILI has celebrated it's 25th Anniversary on November 19, 2014.  

16th November 2014
9th EVICR.net Members Meeting
The 9th EVICR.net Members Meeting took place on 16 and 18 November 2014 in Coimbra - Portugal, at AIBILI. For more information please visit the EVICR.net website.

5th November 2014
Pharmacovigilance: Updates on drug safety – quarterly publication; Vol. 1, Nº 3; 05/11/2014 // Farmacovigilância: Atualizações de segurança de medicamentos – Vol. 1, Nº 3; 05/11/2014
Pharmacovigilance: Updates on drug safety is a quarterly publication issued by the Portuguese Central Regional Pharmacovigilance Unit (UFC) delivering to patients and healthcare professionals information on the risks and safe use of medicines.

Farmacovigilância: Atualizações de segurança de medicamentos é uma publicação trimestral editada pela Unidade de Farmacovigilância do Centro (UFC) com o objetivo de disponibilizar informação de segurança dos medicamentos aos utentes e profissionais de saúde.

24th October 2014
Prof. Cunha-Vaz receives the 2014 Albert Muse Prize
The Albert C. Muse Prize was established in 2001 by the Eye & Ear Foundation of Pittsburgh, USA, to honor world leaders in the fields of ophthalmology and otolaryngology. The Muse Prize 2014 recognize Prof. Cunha-Vaz who have made significant, progressive contributions to science and medicine in the Ophthalmology field.  

4th October 2014
Prof. José Cunha-Vaz receives the National Health Award 2014
Prof. José Cunha-Vaz receives the National Health Award 2014 - Prémio Nacional de Saúde 2014. The National Health Award 2014 - Prémio Nacional de Saúde 2014 is assigned by the Health Directorate General - Direção-Geral da Saúde anually.

21st July 2014
Pharmacovigilance: Updates on drug safety – quarterly publication; Vol. 1, Nº 2; 18/07/2014 // Farmacovigilância: Atualizações de segurança de medicamentos – Vol. 1, Nº 2; 18/07/2014
Pharmacovigilance: Updates on drug safety is a quarterly publication issued by the Portuguese Central Regional Pharmacovigilance Unit (UFC) delivering to patients and healthcare professionals information on the risks and safe use of medicines.

Farmacovigilância: Atualizações de segurança de medicamentos é uma publicação trimestral editada pela Unidade de Farmacovigilância do Centro (UFC) com o objetivo de disponibilizar informação de segurança dos medicamentos aos utentes e profissionais de saúde.

20th May 2014
Dia da Porta Aberta da Inovação Biofarmacêutica
A AIBILI foi escolhida pela APIFARMA, no âmbito da comemoração dos seus 75 anos, para a realização de uma sessão do Dia da Porta Aberta da Inovação Biofarmacêutica, no dia 20 de Maio. Programa.

5th May 2014
ARVO 2014 Achievement awards - Prof. Cunha-Vaz receives the Weisenfeld Award
Prof. Cunha-Vaz has received the Weisenfeld Award 2014 in Orlando, USA, during the ARVO Meeting. The Weisenfeld Award is presented annually to an individual in recognition of distinguished scholarly contributions to the clinical practice of ophthalmology. More information can be obtained here.

15th April 2014
Pharmacovigilance: Updates on drug safety – quarterly publication; Vol. 1, Nº 1; 15/04/2014 // Farmacovigilância: Atualizações de segurança de medicamentos – Vol. 1, Nº 1; 15/04/2014
Pharmacovigilance: Updates on drug safety is a quarterly publication issued by the Portuguese Central Regional Pharmacovigilance Unit (UFC) delivering to patients and healthcare professionals information on the risks and safe use of medicines.

Farmacovigilância: Atualizações de segurança de medicamentos é uma publicação trimestral editada pela Unidade de Farmacovigilância do Centro (UFC) com o objetivo de disponibilizar informação de segurança dos medicamentos aos utentes e profissionais de saúde.

6th March 2014
AIBILI Annual Report 2013
AIBILI Annual Report 2013 is now available. Please donwload here the report.

12th February 2014
Pharmacovigilance: Updates on drug safety – quarterly publication; Vol. 1, Nº 0; 12/02/2014 // Farmacovigilância: Atualizações de segurança de medicamentos – Vol. 1, Nº 0; 12/02/2014
Pharmacovigilance: Updates on drug safety is a quarterly publication issued by the Portuguese Central Regional Pharmacovigilance Unit (UFC) delivering to patients and healthcare professionals information on the risks and safe use of medicines.

Farmacovigilância: Atualizações de segurança de medicamentos é uma publicação trimestral editada pela Unidade de Farmacovigilância do Centro (UFC) com o objetivo de disponibilizar informação de segurança dos medicamentos aos utentes e profissionais de saúde.

30th January 2014
Inauguration ceremony of ECRIN-ERIC
ECRIN-ERIC is a network dedicated to improving the health of patients and citizens across the world through clinical research. ECRIN-ERIC was officially awarded the Community legal framework for a European Research Infrastructure Consortium (ERIC).  This specific legal form is designed to facilitate the joint establishment and operation of research infrastructures of European interest. The inauguration cerimony took place on January 30, 2014 in Brussels, Belgium. Please find here the Press Release.
AIBILI, as Coordinating Centre of EVICR.net, is also proceeding to become an Affiliate Partner of ECRIN-ERIC as a disease-oriented clinical research network.

27th June 2013
3rd Annual Coimbra Champalimaud Symposium
The 3rd Annual Coimbra Champalimaud Symposium was held in Coimbra on 27/06/2013 with the institutions recognized as C-TRACER by the Champalimaud Foundation: LV Prasad Eye Institute in India, AIBILI in Coimbra and the Federal University of São Paulo, Brazil. Please download here the program and press release.

18th June 2013
AIBILI as a Case Study
It was recently published the study "Clinical trials in Portugal" promoted by APIFARMA and conducted by PwC. Please download here the publication. AIBILI is presented and detailed as a case study in managing and performing investigator-driven and industry-driven clinical trials.

3rd June 2013
VICT - Vision and Imaging Consortium for Translational Research
A Vision and Imaging Consortium for Translational Research (VICT) was established bringing together the following institutions: IBILI - Institute for Biomedical Imaging and Life Sciences of the Faculty of Medicine, AIBILI - Association for Innovation and Biomedical Research on Light and Image, ICNAS - Institute for Nuclear Sciences Applied to Health, and CRIO - University Clinic of Ophthalmology of the Coimbra University Hospital.
The VICT aggregates institutions covering the entire translational process in Vision and Imaging, from the molecular development to clinical practice and patient care.

15th May 2013
Prof. Cunha-Vaz receives the 2014 Mildred Weisenfeld Award for Excellence in Ophthalmology
The Mildred Weisenfeld Award for Excellence in Ophthalmology is presented to Prof. Cunha-Vaz in recognition of distinguished scholarly contributions to the clinical practice of ophthalmology. Prof. Cunha-Vaz will present a lecture and will be given a plaque at the 2014 ARVO Annual Meeting.

30th April 2013
Prof. Cunha-Vaz receives the 2012 Bial Award of Clinical Medicine.
Prof. Cunha-Vaz received the 2012 Bial Award of Clinical Medicine for his work "Diabetic Retinopathy: new perspectives for personalized treatment." The ceremony for the awards was held on May 14, at the Institute of Biomedical Sciences Abel Salazar, Porto, Portugal.

20th March 2013
AIBILI Activities and Financial Report 2012 approved
The AIBILI General Assembly approved the Activities and Financial Report of 2012. You can find these documents in the Press Release area of our website.

5th February 2013
Clinical Trial using innovative eye drop treatment to combat Diabetic Retinopathy
A Clinical Trial to test the safety and effectiveness of a new therapeutic treatment to combat diabetic retinopathy begin in February 2013 in 11 EVICR.net clinical centres across the EU as part of the EUROCONDOR project. [read more]

14th December 2012
1st Annual São Paulo Champalimaud Symposium
Within the context of the C-TRACERs Network of the Champalimaud Foundation it was organized in São Paulo, Brazil, by the local C-TRACER the 1st Annual São Paulo Champalimaud Symposium. AIBILI was represented by Prof. Cunha-Vaz and Dr. Martinho.

30th November 2012
Workshop: New Technologies for Medical Imaging
An workshop on New Technologies for Medical Imaging was held at AIBILI on 30/11/2012. Please find here the Programme.

16th November 2012
Workshop: Investigator-Driven Clinical Trials
An workshop on Investigator-Driven Clinical Trials was held at AIBILI on 16/11/2012. Please find here the Programme and the Press Release.

27th June 2012
AIBILI External Scientific Council Meeting
AIBILI has organized on 27/06/2012 the External Scientific Council Meeting. This meeting is part of the regular evaluation process of AIBILI which takes place every three year. [read more]

25th May 2012
Prof. Cunha-Vaz receives Gian Battista Bietti SOI Medal
Gian Battista Bietti Medal of the Italian Society of Ophthalmology is the highest distinction of this society. [read more]

19th April 2012
16th National Congress of Medicine
The 16th National Congress of Medicine took place between 17 and 20 of April 2012, in Coimbra, organized by the Ordem dos Médicos.
Prof. Cunha-Vaz was one of the invited speakers and has made a talk on Clinical Research - Quality Assurance in AIBILI.

12th April 2012
AIBILI on the Campeão das Províncias
Following an interview of Prof. Cunha-Vaz to the Campeão das Províncias magazine an article was published in this magazine about AIBILI as Coordinating Centre of the EVICR.net - the European Network of Clinical Research Centres in Ophthalmology. Please download here the article.

30th March 2012
AIBILI report on the OftaPro
Following an interview of Prof. Cunha-Vaz to the OftalPro magazine an article about AIBILI was published in this magazine. Please download here the entire article.

20th March 2012
National Clinical Trials Platform (PNEC)
The presentation of the PNEC, developed by Infarmed, was held in Lisbon on 20/03/2012. The Portuguese Health Minister said on Tuesday that the creation of the National Clinical Trials Platform (PNEC) is "an important step" to attract clinical research of "high quality" and increase the number of trials taking place in Portugal. [read more]

28th February 2012
RDSS - Retinal Disease Screening System
The Retinal Disease Screening System project submitted by AIBILI in partnership with Critical Health to QREN was approved. [read more]

23rd February 2012
2nd Portuguese BioEngineering Meeting
The 2nd Portuguese BioEngineering Meeting took place in Coimbra, Portugal, on February 23-25, 2012, organized by the IEEE EMBS Portuguese Chapter. AIBILI sponsored this meeting. For more information please visit http://www.aibili.pt/engbiomed/.

13th January 2012
Interview of Prof. José Cunha-Vaz
Please find here an interview of Prof. José Cunha-Vaz "The difference that makes Coimbra" to the Diário de Coimbra published on 12/01/2012.

11th November 2011
Ciclo de Divulgação - Health Technology Assessment - Capacity Building and Business Model
Esta sessão realizou-se no dia 11/11/2011.

14th October 2011
Formação em INVESTIGAÇÃO CLÍNICA
A AIBILI organizou em Coimbra em 14 de Outubro de 2011 uma Formação em Investigação Clínica. [read more]

4th May 2011
AIBILI integra a Rede de Investigação Farmacoepidemiológica da Agência Europeia do Medicamento
A AIBILI através do HTA integrou recentemente a ENCePP - European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. [read more]

14th April 2011
Ciclo de Divulgação AIBILI - Próximas Sessões
As próximas sessões do Ciclo de Divulgação decorrerão em:
- 21/10/2011 dedicada a Produtos Biosimilares 
- 11/11/2011 dedicada a In Vivo Ocular Imaging

23rd March 2011
Foundation Champalimaud became Honorary Associate Member of AIBILI
As proposal of the Board the AIBILI General Assembly assigned the title of Honorary Associate Member to the Champalimaud Foundation as result of its recent and relevant cooperation with AIBILI, including the designation of C-TRACER-Champalimaud Translational Centre for Eye Research.

23rd March 2011
I&D em Oftalmologia
Faça download aqui do artigo "I&D em Oftalmologia" do Sr. Prof. Doutor José Cunha-Vaz publicado na Saúde em Revista de 6 de Março de 2011.

29th October 2010
Formação em INVESTIGAÇÃO CLÍNICA
A AIBILI organizou em Coimbra em 29 e 30 de Outubro de 2010 uma Formação em Investigação Clínica de acordo com este programa.

6th October 2010
AIBILI reconhecida como C-TRACER pela Fundação Champalimaud
No dia 6 de Outubro de 2010 a AIBILI foi publicamente reconhecida como um C-TRACER Champalimaud - Translational Centre for Eye Research pela Fundação Champalimaud. Encontra aqui o press release com informação mais detalhada.

29th September 2010
Investigação Inovadora em Retinopatia Diabética
Investigação desenvolvida na AIBILI e IBILI no âmbito de um projecto financiado pela empresa OM Pharma permitiu identificar e esclarecer os mecanismos de acção de um fármaco, dobesilato de cálcio (Doxium), usado há algumas décadas no tratamento da retinopatia diabética. Mais informação aqui.

1st June 2010
Retmarker recebe Menção Honrosa no prémio Produto Inovação COTEC-UNICER
O Retmarker foi ontem distinguido com uma Menção Honrosa no prémio Produto Inovação COTEC-UNICER, prémio atribuído pela Associação Empresarial para a Inovação (COTEC) e UNICER, com o apoio do Jornal Expresso. [read more]

16th March 2010
Retmarker fundus imaging software granted with CE 0197 Mark
Retmarker fundus imaging software was granted with the CE 0197 mark for medical purposes according with Council Directive 93/42/EEC. [read more]

1st June 2009
At Euretina'09, Critical Health Showcases a Breakthrough in Predicting Diabetic Retinopathy Progression
Critical Health and AIBILI Partnership Develops Innovative Diabetic Retinopathy Progression Biomarker Software. Product available / More information: http://www.retmarker.com/

Copyright © 2017 AIBILI   -   Contact Us   -   Site Map   -   Webdesign Glitz Design   -   Programming Bizview